Alectinib Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Alectinib Hydrochloride
Health Canada Patents

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

Alectinib Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

25 API Suppliers, 6 USDMF, 2 EU WC, 6 NDC API, 17 Listed Suppliers, $ API Reference Price

25 API Suppliers
6 USDMF
2 EU WC
6 NDC API
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

60 Drugs in Development

60 Drugs in Development

INTERMEDIATES

17 Intermediate Suppliers

17 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

3 FDF Dossiers, 1 FDA Orange Book, 1 Europe, 1 Canada

3 FDF Dossiers
1 FDA Orange Book
1 Europe
1 Canada

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 3 SPI Pharma, 7 DKSH, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 1 ACG Worldwide, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 3 Gangwal Chemicals, 3 Ideal Cures, 2 Ingredion Pharma Solutions, 18 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 1 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 8 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Sigachi Industries, 1 Silverline Chemicals, 2 The Dow Chemical Company, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives, 27 Fillers, Diluents & Binders, 13 Granulation, 13 Controlled & Modified Release, 11 Direct Compression, 10 Lubricants & Glidants, 9 Thickeners and Stabilizers, 7 Taste Masking, 6 Film Formers & Plasticizers, 6 Disintegrants & Superdisintegrants, 6 Rheology Modifiers, 5 Empty Capsules, 4 Co-Processed Excipients, 4 Vegetarian Capsules, 4 Coloring Agents, 4 Chewable & Orodispersible Aids, 3 API Stability Enhancers, 3 Emulsifying Agents, 3 Parenteral, 1 Soft Gelatin, 1 Surfactant & Foaming Agents, 1 Solubilizers, 1 Topical

41 Coating Systems & Additives
27 Fillers, Diluents & Binders
13 Granulation
13 Controlled & Modified Release
11 Direct Compression
10 Lubricants & Glidants
9 Thickeners and Stabilizers
7 Taste Masking
6 Film Formers & Plasticizers
6 Disintegrants & Superdisintegrants
6 Rheology Modifiers
5 Empty Capsules
4 Co-Processed Excipients
4 Vegetarian Capsules
4 Coloring Agents
4 Chewable & Orodispersible Aids
3 API Stability Enhancers
3 Emulsifying Agents
3 Parenteral
1 Soft Gelatin
1 Surfactant & Foaming Agents
1 Solubilizers
1 Topical

DIGITAL CONTENT

41 News #PharmaBuzz

41 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 8 Annual Reports

1 US Medicaid Prescriptions
8 Annual Reports

MARKET PLACE

7 APIs, 1 FDF Dossiers

7 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 US Patents, 2 US Exclusivities, 4 Health Canada Patents

5 US Patents
2 US Exclusivities
4 Health Canada Patents

$ API Ref.Price (USD/KG) : 18,515 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Gowling WLG (Canada) LLP

filter Patent Reset all filters

4 All

01 12764653

02 12808210

03 12946518

04 13140565

filter Product Reset all filters

4 All

01 4ALECTINIB HYDROCHLORIDE

filter Dosage Reset all filters

4 All

01 4CAPSULE

filter Exp Date Reset all filters

4 All

01 12030-06-09

02 12031-08-19

03 22035-04-24

Product Main Page

01

Gowling WLG (Canada) LLP

ALECTINIB HYDROCHLORIDE

PREP

Not Confirmed

Gowling WLG (Canada) LLP

Country

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-06-09

Date Granted : 2018-01-02

ALECTINIB HYDROCHLORIDE

Brand Name : ALECENSARO

Patent Number : 2764653

Filing Date : 2010-06-09

Strength per Unit : 150 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-06-09

Date Granted : 2018-01-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Gowling WLG (Canada) LLP

ALECTINIB HYDROCHLORIDE

PREP

Not Confirmed

Gowling WLG (Canada) LLP

Country

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-19

Date Granted : 2019-10-01

ALECTINIB HYDROCHLORIDE

Brand Name : ALECENSARO

Patent Number : 2808210

Filing Date : 2011-08-19

Strength per Unit : 150 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-08-19

Date Granted : 2019-10-01

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Gowling WLG (Canada) LLP

ALECTINIB HYDROCHLORIDE

PREP

Not Confirmed

Gowling WLG (Canada) LLP

Country

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-04-24

Date Granted : 2022-07-26

ALECTINIB HYDROCHLORIDE

Brand Name : ALECENSARO

Patent Number : 2946518

Filing Date : 2015-04-24

Strength per Unit : 150 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-04-24

Date Granted : 2022-07-26

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Gowling WLG (Canada) LLP

ALECTINIB HYDROCHLORIDE

PREP

Not Confirmed

Gowling WLG (Canada) LLP

Country

PREP

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-04-24

Date Granted : 2022-10-11

ALECTINIB HYDROCHLORIDE

Brand Name : ALECENSARO

Patent Number : 3140565

Filing Date : 2015-04-24

Strength per Unit : 150 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-04-24

Date Granted : 2022-10-11

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!